Background. The potential role of myocardial cell hypertrophy in the ischemic zone in the mechanism of late recovery of regional contractile function after myocardial infarction followed by reperfusion has not been examined.
R ecovery of regional contractile function provides a marker for one of the important goals of coronary artery reperfusion, salvage of functioning left ventricular (LV) myocardium. A number of experimental studies in dogs have demonstrated that when coronary artery reperfusion is performed within 2-4 hours after coronary occlusion, there is some recovery of regional myocardial function. Little is known, however, about the mechanisms that underlie such recovery of regional and global ventricular function after reperfusion after prolonged periods of severe myocardial ischemia. Previous studies in this laboratory showed that coronary artery reperfusion after 3 hours of occlusion can result in very early return of regional function (assessed by cineradiography and opaque beads) at 30 minutes after reperfusion.1 This observation was later confirmed by experiments in chronically instrumented dogs, in which it was first shown that gradual recovery of regional function occurs over a period of 2-4 weeks after 2 hours of coronary occlusion followed by reperfusion, recovery being greatest at the margin of the ischemic zone but also observed in the central region despite subendocardial tissue loss.2 Reimer et a13 conducted studies on coronary artery occlusion with reperfusion in dogs using quantitative histology and reported epicardial sparing after 3 hours of coronary occlusion followed by reperfusion, as suggested in experiments by others showing sparing of outer wall myocardial creatine kinase at 1 week after 3
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Circulation Vol 86, No 6 December 1992 hours of coronary occlusion with reperfusion. 4 Reimer et a13 further demonstrated a "wave front" of spreading necrosis from endocardium to epicardium over 6 hours. Sasayama et als reported that the thickness of infarcted wall after permanent coronary artery occlusion in dogs showed minimal thinning at 3 weeks, despite scar formation, suggesting the possibility of compensatory hypertrophy of undamaged cells in the infarct zone. Subsequent studies also documented recovery of regional function after reperfusion6-9 together with improved survival and reduced infarct size67 and biochemical recovery. 8 On the basis of these observations, we hypothesized that hypertrophy of surviving subepicardial cells and/or surviving islands of cells in the infarcted subendocardial or midwall areas might occur and contribute to regional functional recovery after coronary artery occlusion after reperfusion. Therefore, in this study in a canine model, we examined over 3 weeks the potential for regional cellular hypertrophy after reperfusion following 90-120 minutes of coronary occlusion together with assessment of regional wall dimensions and functions. Methods The animals in this study were handled according to the animal welfare regulations of the University of California San Diego, which are in accord with the animal use principles of the American Heart Association, and the protocol was approved by the Animal Use Committee of this institution.
Animal Preparation
Thirty mongrel dogs of both sexes weighing between 19.0 and 40.0 kg (mean weight, 28.3 kg; mean age, 1.8 years) were trained to lie on a table before surgical instrumentation. On the day of surgery, dogs were tranquilized with morphine (10.5 mg/kg i.m.) and anesthetized with sodium thiamylal (20 mg/kg i.v.). After endotracheal intubation, anesthesia was maintained with isoflurane (1-2%). Arterial blood gases were measured repeatedly throughout the surgery, and ventilatory adjustment was made as necessary to keep Po2 above 150 mm Hg and Pco2 and pH within the physiological range. The heart was exposed through a left lateral thoracotomy in the fifth intercostal space, and the pericardium was opened. A high-fidelity micromanometer (Konigsberg P7) and a Tygon fluid-filled catheter (1.27-mm i.d.) were inserted through a stab wound in the apex to measure LV pressure. The micromanometer was calibrated by matching it to the ventricular pressure through the fluid-filled catheter (Statham P-23Db), and the zero pressure reference was taken at the estimated level of the right atrium. Silicon rubber catheters were inserted into the upper descending aorta and left atrium through the atrial appendage, and a pair of pacing electrodes was sutured on the left atrial appendage. The thickness, two pairs of crystals were implanted, one for total wall thickness and the other to measure subepicardial wall thickness ( Figure 1) . Thickness of the PT transmural (PTtm) and PT epicardial (PTepi) sites was measured, and the PT endocardial (PTendo) thickness was calculated by subtracting the epicardial layer thickness from the total thickness. The pericardium was left open, and all wires and the catheters were passed subcutaneously to the back of the dog and brought through the skin between the scapulae. The thorax was evacuated through a chest tube in the sixth intercostal space. Cefazolin (500 mg/kg i.m.) was administered 1 hour before surgery and every 3 hours throughout the procedure for a total of three doses.
Protocols
Control studies were conducted 1-2 weeks after surgery, when the animals had recovered fully, and all data were obtained with the animal lying quietly on a table. Sedation and analgesia were used only at the time of coronary occlusion. After control hemodynamic recordings were collected at the intrinsic and several paced heart rates, the dog was given acepromazine (5-10 mg i.m.) and buprenorphine (0.3 mg i.m.) for analgesia and sedation. Radiolabeled microspheres (15.5 ,um in diameter) were injected through the left atrial catheter, and a reference blood sample was withdrawn from the aortic catheter for 90 seconds, starting just before the microsphere injection. Before coronary occlusion, lidocaine (20-40 mg bolus) was injected through the LV catheter and 1-2 mg/min was then continuously infused to minimize arrhythmias. Coronary arterial occlusion was performed by inflating the Silastic occluder with air or water, and the occlusion was maintained for 90 minutes (in two dogs, the occlusion was 120 minutes). During occlusion, heart rate, ECG, LV and aortic pressures, wall thickness, and coronary flow (Doppler flowmeter) were continuously monitored.
After occlusion for 80 minutes, hemodynamic recordings were repeated, and another batch of microspheres was injected. Before reperfusion, a bolus of lidocaine (20-40 mg) was again administered, and when the heart rate was < 130 beats per minute, the atrium was paced 20-30 beats per minute faster than the intrinsic rate for the first 15 minutes of reperfusion to further minimize dysrhythmias.2 Two hours after reperfusion, another set of recordings was made, and each dog was transferred to a recovery cage. Tocainide (600 mg/day p.o.) was given for the first 3 days. Hemodynamic recordings were repeated on days 1, 2, and 3 and at 1, 2, and 3 weeks. Radiolabeled microspheres were injected at 24 hours and 3 weeks after reperfusion. Atrial pacing was used to match heart rates to the control heart rate when necessary.
The animals were killed after 3 weeks of reperfusion. Under general anesthesia, a left thoracotomy was performed, the heart was exposed, and a fixative (2% glutaraldehyde in buffer and 4% paraformaldehyde) was infused via the coronary orifice of the left main trunk. The perfusion pressure was kept between 120 and 150 mm Hg. After the heart was properly fixed, transmural tissue blocks that contained a pair of crystals were cut and divided into the three layers (subepicardial, midwall, and subendocardial layers). The Myocardial tissues were first used for RBF measurements, and then small blocks were cut from the endocardial, midwall, and epicardial tissue samples in a plane perpendicular to the epicardial surface. These were embedded in paraffin, sliced at a thickness of 5 gm, and stained with Milligan trichrome stain for analysis of scar formation. Percent infarction (percent scar formation) was measured by a computer-assisted point counting method (final magnification, x25).
The remaining tissue in each of the endocardial, midwall, and epicardial samples was then divided into 15-20 pieces, excluding visible subendocardial scar. A binocular dissecting microscope was used to identify fiber cross-striations so that blocks could be cut as closely as possible perpendicular to the cross-striations. This yielded multiple blocks from each of the endocardial, midwall, and epicardial regions sampled by the larger transmural blocks from the infarcted wall and the normal zone. These small tissue blocks were then dehydrated and treated in OS04. 
Results

Hemodynamic Parameters
Representative original tracings are shown in Figure  2 . Hemodynamic parameters under control conditions are shown in Table 1 . The average heart rate was slightly increased during coronary occlusion but did not change significantly throughout the experimental period, and atrial pacing was not required. LV end-diastolic pressure during coronary occlusion and at 3 weeks was not significantly different from control. Peak LV pressure decreased slightly during occlusion and was significantly reduced at 2 hours after reperfusion. Peak positive dP/dt decreased slightly during early reperfusion, but there were no statistically significant changes. 26 .5%, and PTtm, PTepi, and calculated PTendo were 24%, 19%, and 32%, respectively. The ischemic wall showed dyskinesia during occlusion, quickly recovered partially during the first 2 days after reperfusion, and then gradually improved further over the 3 weeks after reperfusion (shown as PTtm and PTepi in Figure 3 ). PTtm recovered to 67% of control by 3 weeks. Recovery of systolic wall thickening appeared somewhat greater for PTepi than for PTendo (Table 2) ; however, the scatter in the calculated values of PTendo was wide. The %WT of PTtm remained significantly depressed after reperfusion ( Table 2 ).
The %WT of the AT wall tended to increase during coronary occlusion, but the changes were not significant (p=NS). At 3 weeks of reperfusion, %WT of AT tended to be higher than control, but the difference was not statistically significant (Table 2) .
End-diastolic wall thickness. Under control conditions, end-diastolic wall thickness of the AT wall, PTtm, PTepi, and calculated PTendo were 11.6, 12.4, 7.2, and 5.2 mm, respectively. PTep; was 58% and PTendo 42% of PTtm (Table 2 ). After reperfusion, PTu, thickness increased markedly above control (Figure 3 ), then gradually decreased, and at 3 weeks after reperfusion it was not significantly different from the control level (Table 2) . AT (control) wall thickness increased slightly during the last two weeks (p=NS). At 3 weeks, all wall thicknesses were not significantly different from control (Table 2) .
Regional Blood Flow
The RBF data in the dogs with infarction are shown in Table 3 Figure 4 . During coronary occlusion, there was subendocardial ischemia. One day after reperfusion and at 3 weeks, the RBF had recovered, and at 3 weeks there were no significant differences from 1 day and control across the wall in the ischemic zone (Table 3 ). The AT wall RBF remained normal throughout the experiment (Figure 4 ). Scar Formation Scar formation was found in all three layers in the samples from the PT walls of dogs with infarction. Percent infarction (average percent scar formation) was greatest in the subendocardium and least in the subepicardium: 4.8% in the subepicardium, 10.0% in the midmyocardium, and 34.0% in the subendocardium. Scar formation >1% was not found in the AT walls in any of the dogs without infarction or in either wall of the sham-operated dogs. Figure 5 ). In dogs with infarction, the endocardial cell areas were significantly larger than the epicardial cell areas in both the AT and PT walls (Figure 6 ), and the endocardial-to-epicardial cell area ratios were abnormal (Figure 7 ). In dogs with infarction, cell areas were significantly larger in the PT wall than in the AT wall ( Figure 6 In dogs without infarction, differences in cell areas between the AT and PT walls or across the walls were not significant ( Figure 5 ). Discussion It is generally agreed that compensatory myocardial hypertrophy of the volume overload type often occurs in normal regions after myocardial infarction, but little is known about the response of surviving cells in the infarcted area. Hypertrophic responses in the ischemic zone could have an important role in the functional recovery of that region and the whole heart after myocardial infarction, particularly after reperfusion. Considering that myocardial necrosis after infarction is often nontransmural in human subjects, especially after successful thrombolysis, coronary angioplasty, or spon- 0 taneous recanalization in the acute phase, the present study in dogs was designed to evaluate the potential for surviving cells in a zone associated with nontransmural myocardial infarction to undergo hypertrophy during the time that recovery of regional function is under way after reperfusion.
Responses of Regional Wall Motion and Thickness
The relatively small hemodynamic changes observed suggest that the extent of subendocardial infarction in these dogs at 3 weeks was not large, a supposition supported by the observed degree of subendocardial necrosis (34%); however, shrinkage of the scar in the infarct region occurs16 and would not be manifested in our estimates of percent necrosis, leading to underestimation of the original degree of necrosis. The early rapid increases of wall thickness in the ischemic zone at end diastole likely represent edema after reperfusion (Figure 3 ). At the end of the study period (3 weeks), the end-diastolic thicknesses of the AT wall, PTtm, and PTep; walls were slightly increased, but changes were not statistically significant, and in the absence of measures of global ventricular geometry, these responses cannot be interpreted in terms of myocardial hypertrophy. However, any increase in chamber diameter or scar formation in the infarcted wall should reduce the transmural wall thickness, suggesting that the lack of significant change in the transmural thickness of the infarct zone ( Figure 3 ) was a result of regional hypertrophy. We hypothesize that the recovery of regional function represents a combination of resolution of stunning during the first week and later changes mediated, at least in part, by hypertrophy primarily of the outer wall, which was ischemic during the coronary occlusion (Figure 4) . In the present study, however, these relative contributions of hypertrophy to functional recovery cannot be determined with certainty. Others have reported that the epicardial half of the wall shows better early recovery from stunning than the transmural wall.17 
Myocardial Cellular Hypertrophy
The fact that gross cardiac hypertrophy is often associated with myocardial infarction in human subjects is known from postmortem studies,18-20 and recent postmortem findings have reported myocardial cellular hypertrophy in the outer third of the infarcted wall in some human subjects20 as well as in the noninfarcted wall21 1 month or more after infarction. Studies in rats with permanent coronary artery occlusion have demonstrated that myocardial cellular hypertrophy occurs late after infarction,22-28 but hypertrophy can be an early event occurring within 1 week, as also demonstrated by studies in other models such as pressure overload.29 It has been shown that myocardial cellular hypertrophy in rats was present in the noninfarcted wall with large infarctions,27,28 and Olivetti et a122 demonstrated hypertrophic responses of surviving myocardium to be greatest close to the site of transmural infarction. In rats, the infarction caused by permanent coronary artery occlusion is usually transmural, with little spared myocardium in the outer wall. Also, in rats with transmural infarction and heart failure that were studied late (up to 6 months), Zimmer et a128 reported that hypertrophy was evident only by examining cell length (cross-sectional areas unchanged).
Our observations concern responses with smaller infarcts after coronary artery reperfusion at an earlier time and in a different species. To the best of our knowledge, they represent the first in which myocardial cellular responses to coronary occlusion with reperfusion have been examined transmurally in both noninfarcted and infarcted regions. In these dogs, at 3 weeks after reperfusion, the infarcted wall showed recovery to 67% of control systolic %WT, and myocardial cellular hypertrophy was observed both in the AT (noninfarcted) wall and in surviving cells throughout the PT (infarcted) wall, with cells in the infarcted region being larger than in normal regions and with the largest cells being in the subendocardium. The reason for the observed abnormal endocardial/epicardial ratio of cell area in the infarcted region is uncertain, but variations in regional wall stress may be one factor. An abrupt decline of LV performance after coronary occlusion causes LV dilation, at least for a period, and therefore regional wall stress will probably increase in both infarcted and normal walls. The subsequent abnormal chamber geometry could produce abnormal stress distributions. It has been reported that stretch of cultured myocardial cells produces a hypertrophic response,30 and such an effect around the infarcted site, as well as temporary regional ischemia,3' might evoke regional hypertrophy through activation of growth or other factors affecting upregulation of contractile protein gene expression.32,33 Thus, the pattern of hypertrophy in the reperfused zone noted in the present study suggests that a significant role is played by local factors, which remain to be investigated.
There was variability in the degree of cell area enlargement, but the reason for this finding is not entirely clear. At 3 weeks, there was a good inverse correlation between the percent scar formation in the subendocardial sample and the systolic %WT normalized to the control %WT (r=0.99, p<0.002), increased percent scar being correlated with decreased wall function as previously reported.16 One animal with infarction in which myocardial cell areas were unusually small (dog 5) had the least percent scar in the subendocardial region at 3 weeks (8%), at which time function had returned to normal. In other animals, the degree of subendocardial scar ranged between 18% and 70%, but there were no significant correlations between scar in the subendocardium (or the subendocardium plus the midwall) and cell areas (subendocardial or mean), although subendocardial cells were clearly larger in the infarcted than the control wall in four animals (infarcted wall) and five animals (AT wall). Thus, although there was cell area enlargement in the infarcted and normal regions, which could have contributed to the return of function observed in each animal, a mechanism for the considerable diversity of the response in cell areas cannot be identified in this relatively small series of animals.
Limitations of the Study
There are several limitations to the present study. We evaluated regional rather than global ventricular performance or geometry. Thus, the effect of the severity of the infarction and subsequent recovery on overall LV performance was not evaluated. Substantial changes in global LV performance appear unlikely, however, because hemodynamic parameters such as mean aortic pressure, LV end-diastolic pressure, and peak systolic LV pressure were unchanged at 3 weeks after reperfusion. We did not attempt to measure myocardial infarct size in these animals because of the heavy instrumentation, the need to remove blocks at the site at which instrumentation was implanted, and previous knowledge that the infarcted area would be rather small in this reperfusion model. However, we examined the infarct histologically at a central site to ensure the presence of tissue necrosis and to exclude dogs without significant infarct. We examined cellular hypertrophy as the cell cross-sectional area, without assessment of cell length or volume. The cell area measurements alone showed significant hypertrophy, however, consistent with the observed preservation of ventricular end-diastolic wall thickness in the ischemic region (despite subendocardial infarction). Cell length changes have been documented with more chronic transmural infarction in rats associated with LV dilation.28 Stretching of cells with changes in cell length could have further increased cell volume, and even in the presence of hypertrophy, elongation could have caused no change or a reduction in cell cross-sectional area, as observed in rats with transmural infarction28; if such changes had occurred in our experiments, they would have resulted in underestimation of the degree of hypertrophy, based on cross-sectional cell areas. However, with the relatively small nontransmural infarcts produced in the present study, significant ventricular dilation would not be expected at 3 weeks, as supported by the lack of LV end-diastolic wall thinning of the noninfarcted AT wall at any time point (Table 2 ). Cell areas were relatively consistent within groups, except for one dog in the infarct group that showed unusually small cells but with a markedly abnormal endocardial/epicardial cell ratio. Because the same tissue preparation methods were used in all animals, and cell areas are consistent with previous reports,23,28 comparisons between the infarcted and noninfarcted groups should be valid.
